Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
preclinical
Biotech
Evotec makes 'strategic exit' from gene therapy space
A month after Evotec first alluded to a “strategic reset,” the German biotech has revealed the end of its gene therapy aspirations.
James Waldron
May 22, 2024 9:22am
Moderna CEO: Mpox vaccine development is not a high priority
Jan 4, 2023 9:49am
Blueprint drops $250M on Lengo for preclinical lung cancer med
Nov 29, 2021 10:20am
Roche's Spark adds epilepsy asset to pipeline with $328M deal
Oct 12, 2021 10:25am
Abata launches with $95M series A for MS cell therapy
Jun 23, 2021 7:00am
TRexBio roars with dino-mite snags of CEO, CMO, Big Pharma cash
Jun 22, 2021 10:50am
